MI Biotech Consulting ApS: Financial statements 2025
CVR: 43476238
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
MI Biotech Consulting ApS (CVR 43476238) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 489,882 and a net result of DKK -115,163 compared with DKK 254,966 the year before. That is a decrease of 46.4% compared with the year before. Equity in the 2025 report amounted to DKK 684,087. The solvency ratio was 74.6%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 489,882
- Profit/Loss
- DKK -115,163
- Equity
- DKK 684,087
- Total Assets
- DKK 916,946
- Employees
- 1
Official annual report
How creditworthy is MI Biotech Consulting ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
MI Biotech Consulting ApS has published its annual report for 2024. Gross profit came to DKK 914,266, and the net result was DKK 254,966.
About MI Biotech Consulting ApS
MI Biotech Consulting ApS is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2022. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Jesper Mørk. The company is owned by Mørk Innovation ApS. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK 489,882 and a net result of DKK -115,163 compared with DKK 254,966 the year before. Equity in the 2025 report amounted to DKK 684,087.